Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain

The Biochemical Journal
Christian C LeeGlen Spraggon

Abstract

ALK (anaplastic lymphoma kinase) is an RTK (receptor tyrosine kinase) of the IRK (insulin receptor kinase) superfamily, which share an YXXXYY autophosphorylation motif within their A-loops (activation loops). A common activation and regulatory mechanism is believed to exist for members of this superfamily typified by IRK and IGF1RK (insulin-like growth factor receptor kinase-1). Chromosomal translocations involving ALK were first identified in anaplastic large-cell lymphoma, a subtype of non-Hodgkin's lymphoma, where aberrant fusion of the ALK kinase domain with the NPM (nucleophosmin) dimerization domain results in autophosphosphorylation and ligand-independent activation. Activating mutations within the full-length ALK kinase domain, most commonly R1275Q and F1174L, which play a major role in neuroblastoma, were recently identified. To provide a structural framework for understanding these mutations and to guide structure-assisted drug discovery efforts, the X-ray crystal structure of the unphosphorylated ALK catalytic domain was determined in the apo, ADP- and staurosporine-bound forms. The structures reveal a partially inactive protein kinase conformation distinct from, and lacking, many of the negative regulatory features ...Continue Reading

References

Oct 1, 1993·Protein Science : a Publication of the Protein Society·J ZhengL F Ten Eyck
Mar 30, 2001·The Journal of Biological Chemistry·G E StoicaA Wellstein
Jul 10, 2001·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·C E LorénR H Palmer
Nov 6, 2001·Nature Structural Biology·S FavelyukisW T Miller
Jul 18, 2002·The Journal of Biological Chemistry·Gerald E StoicaAnton Wellstein
Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffery L Kutok, Jon C Aster
Dec 10, 2002·Science·G ManningS Sudarsanam
Sep 23, 2003·Acta Crystallographica. Section D, Biological Crystallography·Sanjeev MunshiLawrence C Kuo
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Nov 16, 2004·Nature Structural & Molecular Biology·Jeffrey F OhrenCharles A Hasemann
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jun 20, 2006·Biochemical and Biophysical Research Communications·Takayoshi KinoshitaToshiji Tada
Oct 17, 2006·Cellular and Molecular Life Sciences : CMLS·S W Cowan-Jacob
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andreas KuglstatterMichelle F Browner
Dec 12, 2007·The Journal of Biological Chemistry·Carmen J TartariCarlo Gambacorti-Passerini
Dec 22, 2007·Nature Reviews. Cancer·Roberto ChiarleGiorgio Inghirami
Oct 17, 2008·Nature·Yuyan ChenSeishi Ogawa
Jan 7, 2009·Journal of Molecular Biology·Isaac WestwoodRichard Bayliss
May 23, 2009·The Biochemical Journal·Ruth H PalmerBengt Hallberg
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

May 16, 2012·Lung·Luis Cabezón-GutiérrezMaría Castro-Otero
May 9, 2012·Journal of Medicinal Chemistry·Diane E GingrichBruce D Dorsey
Jan 24, 2012·Journal of Medicinal Chemistry·Marian C BryanRichard T Lewis
Mar 9, 2011·Nature Medicine·Anton Wellstein, Jeffrey A Toretsky
May 16, 2012·Nature Reviews. Clinical Oncology·Erica L Carpenter, Yael P Mossé
Oct 29, 2010·The New England Journal of Medicine·Bengt Hallberg, Ruth H Palmer
Nov 11, 2011·Science Translational Medicine·Scott C BreslerYaël P Mossé
Jan 27, 2012·Science Translational Medicine·Ryohei KatayamaJeffrey A Engelman
May 21, 2011·Cancer Research·Avaniyapuram Kannan Murugan, Mingzhao Xing
Jan 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert C DoebeleD Ross Camidge
Dec 12, 2012·Cancer Discovery·Ron BoseMatthew J Ellis
Oct 31, 2012·International Journal of Molecular Sciences·Kehua WuWilliam C S Cho
Mar 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lindsey M KellyYuri E Nikiforov
Nov 16, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J de Castro-CarpeñoC Belda-Iniesta
Sep 25, 2012·Expert Opinion on Therapeutic Targets·Anna KruczynskiLaurence Lamant
Nov 4, 2015·Cancer Biology & Therapy·Zhihong ZhaoMutian Zhang
Dec 4, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Jan 13, 2016·Cellular and Molecular Life Sciences : CMLS·Richard BaylissMark W Richards
Sep 29, 2011·Seminars in Cancer Biology·Anna M AzarovaRani E George
Sep 24, 2011·Pathology, Research and Practice·Mi Jung KwonYeon-Lim Suh
Nov 17, 2011·Molecular Carcinogenesis·Fiona K E McDuffSuzanne D Turner
Oct 6, 2011·Human Mutation·Loïc de PontualJeanne Amiel
Sep 21, 2012·The Biochemical Journal·Stephen C ArtimMark A Lemmon
Jun 19, 2015·Journal of Molecular Modeling·Zhong Ni, Tian-Cheng Zhang
Aug 22, 2016·Molecular Neurobiology·Neha SamiImtaiyaz Hassan
Jan 24, 2017·Pharmacogenomics·Raffaele PalmirottaFranco Silvestris
Aug 31, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Hallberg, R H Palmer
Aug 2, 2011·Translational Oncology·Christina SchönherrBengt Hallberg
Jan 13, 2018·Journal of Cellular Biochemistry·Muyang HeHongxing Zhang
Nov 15, 2017·Applied Biochemistry and Biotechnology·Nivya JamesK Ramanathan
Nov 20, 2014·Chemical Communications : Chem Comm·Wei Cui, Laurie L Parker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.